Ansun BioPharma
Latest round
- Series B
Last raised
- Jul 2019
Total raised
- $145M
Investors
- 11
About Ansun BioPharma
Founded in 2003 and based in California, US, Ansun BioPharma, Inc. In July 2019, Ansun BioPharma, Inc. The company's line of products includes therapies that prevent, treat, and cure untreatable pandemic flu strains. Ansun BioPharma's pipeline for the DAS181 project is Phase 1, Phase II, and Phase III.
Who invested in Ansun BioPharma
11 investors across 2 rounds
See all investors in Ansun BioPharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Ansun BioPharma
Who invested in Ansun BioPharma?
Ansun BioPharma has 11 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ansun BioPharma raised?
Ansun BioPharma has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Ansun BioPharma last raise money?
Ansun BioPharma's most recent round on record is a Series B, in Jul 2019.
What does Ansun BioPharma do?
Founded in 2003 and based in California, US, Ansun BioPharma, Inc.
Where is Ansun BioPharma headquartered?
Ansun BioPharma is headquartered in San Diego, US.
Which VCs invest in companies like Ansun BioPharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Ansun BioPharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Ansun BioPharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.